Millenium, Takeda Pharma Withdraw SNDA For Relapsed Follicular Lymphoma Therapy RTT News (RTTNews) - Millenium, along with its parent company Takeda Pharmaceutical Co. Ltd. (TKPHF.PK: News ) Thursday reported withdrawing their supplemental new drug application, or sNDA, for Velcade, or bortezomib, to be injected in combination with ... |
Saturday, October 8, 2011
Millenium, Takeda Pharma Withdraw SNDA For Relapsed Follicular Lymphoma Therapy - RTT News
http://goodboxing.net/boxers_172.html
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment